Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck

Author： Lathers D.M.R.   Achille N.J.   Young M.R.I.  

Publisher： Elsevier

ISSN： 0198-8859

Source： Human Immunology, Vol.64, Iss.12, 2003-12, pp. : 1160-1166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck

By Hadden J.   Verastegui E.   Barrera J.L.   Kurman M.   Meneses A.   Zinser J.W.   de la Garza J.   Hadden E.  

International Immunopharmacology, Vol. 3, Iss. 8, 2003-08 ,pp. : 1073-1081

Elsevier

Access to resources Recommend Favorite

Molecular-targeted therapy hypoxia in head and neck squamous cell carcinoma patients (Review)

By Adachi   Thomas  

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 12-14

Spandidos Publications

Access to resources Recommend Favorite

Immunological Approach in the Evaluation of Regional Lymph Nodes of Patients with Squamous Cell Carcinoma of the Head and Neck

By Verastegui E.   Morales R.   Barrera J.L.   Müeller A.   Hadden J.   Guzman B.   Meneses A.   Alfaro G.  

Clinical Immunology, Vol. 102, Iss. 1, 2002-01 ,pp. : 37-47

Academic Press

Access to resources Recommend Favorite

Efficacy of gemcitabine and cetuximab combination treatment in head and neck squamous cell carcinoma

By            

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 918-924

Spandidos Publications

Access to resources Recommend Favorite

Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessment

By  

The Journal Of Pathology: Clinical Research, Vol. 2, Iss. 2, 2016-04 ,pp. : 104-112

John Wiley & Sons Inc

Access to resources Recommend Favorite